Prof Wolvetang is a group leader at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland (Australia), co-director of the UQ Centre “stem cell ageing and regenerative engineering”, leads the “Cell reprogramming Australia” collaborative network, is a principal investigator in the ARC Centre of Excellence “Stem Cells Australia” and was awarded the 2014 LSQ regenerative medicine prize. He obtained his PhD in Biochemistry from the University of Amsterdam, and has published >140 peer reviewed manuscripts. His laboratory employs iPSC as in vitro disease models and uses genome editing to interrogate the underlying gene regulatory networks and epigenetic bases of monogenic and complex neurological diseases.